Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

Completed · Phase 2

Conditions studied: HIV Infections

In brief

The purpose of this study is to study amprenavir/ritonavir, saquinavir/ritonavir or efavirenz in HIV-infected patients following failure with Kaletra (ABT-378/ritonavir) as their first protease inhibitor based HAART.

Key facts

Study ID

NCT00038532

Run by

Abbott

People needed

24

Starts

2001-04-01

Last updated by the study team

2008-04-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Paul J. Cimoch, M.D. — Fountain Valley, California, United States
• AIDS Health Care Foundation - Research Center — Los Angeles, California, United States
• Tower Infectious Diseases Medical Associates — Los Angeles, California, United States
• 20th Avenue Medical Center Kaiser Permanente — Denver, Colorado, United States
• University of Colorado Health Sciences Center — Denver, Colorado, United States
• IDC Research Initiative — Altamonte Springs, Florida, United States
• Gary J. Richmond, M.D. — Fort Lauderdale, Florida, United States
• Associates in Research — Fort Myers, Florida, United States
• University of Miami School of Medicine — Miami, Florida, United States
• Infectious Disease Research Institute, Inc. — Tampa, Florida, United States
• AIDS Research Consortium of Atlanta, Inc. — Atlanta, Georgia, United States
• CORE Center — Chicago, Illinois, United States
• Donna E. Sweet, M.D. — Wichita, Kansas, United States
• David Parks, M.D. — St Louis, Missouri, United States
• Saint Michael's Medical Center — Newark, New Jersey, United States
• Howard A. Grossman, M.D. — New York, New York, United States
• John B. Montana, M.D. — New York, New York, United States
• State University of New York at Stony Brook — Stony Brook, New York, United States
• University of Cincinnati Medical Center — Cincinnati, Ohio, United States
• The Research & Education Group — Portland, Oregon, United States
• Bornemann Internal Medicine — Reading, Pennsylvania, United States
• David Wright, M.D. — Austin, Texas, United States
• University of Texas Medical Branch — Galveston, Texas, United States
• Diversified Medical Practices, P.A. — Houston, Texas, United States
• Phoenix Body Positive, Inc. — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.